𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti–tumor necrosis factor therapy and Listeria monocytogenes infection: Report of two cases

✍ Scribed by T. Glück; H.-J. Linde; J. Schölmerich; U. Müller-Ladner; C. Fiehn; P. Bohland

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
466 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infections and anti–tumor necrosis facto
Infections and anti–tumor necrosis factor α therapy
✍ Todd Ellerin; Robert H. Rubin; Michael E. Weinblatt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

disease, 2 with pleural disease, and 1 each with paravertebral, meningeal, genital, bladder, enteric, and bone disease.

Listeria monocytogenes infection as a co
Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents
✍ Nancy R. Slifman; Sharon K. Gershon; Jong-Hoon Lee; Evelyne T. Edwards; M. Miles 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract ## Objective Tumor necrosis factor α (TNFα) has been implicated in the pathogenesis of certain inflammatory diseases. Two TNFα‐neutralizing agents are licensed in the US. Infliximab is licensed for the treatment of Crohn's disease (CD) and, when used with methotrexate, for the treatmen